FMS

Fresenius Medical Care AG & Co. KGaA (FMS)

Last Price$22.9(1.2%)
Market Cap$13.5B
LTM EPS
$1.6
YoY Growth
-18.2%
3Y CAGR
-4.6%
5Y CAGR
-7.0%
Stock quality & Intrinsic value
6/10
123.9% undervalued

Fresenius Medical Care AG & Co. KGaA EPS

Annual
Quarterly
LTM
Crunching data... Almost there!
Dec'04Dec'05Dec'06Dec'07Dec'08Dec'09Dec'10Dec'11Dec'12Dec'13Dec'14Dec'15Dec'16Dec'17Dec'18Dec'19Dec'20Dec'21Dec'22Dec'23
EPS
$0.6
$0.8
$0.9
$1.1
$1.5
$1.5
$1.6
$1.9
$1.9
$1.8
$1.9
$1.7
$2.1
$2.4
$3.8
$4.4
$4.5
$3.9
$2.4
$1.8
FMS
Key metrics and insights to make informed decisions.
View full analysis
Overvalued or undervalued?
Check the intrinsic value for FMS and see if it's the right time to invest.
Dive in

Fresenius Medical Care AG & Co. KGaA (FMS) EPS comparison analysis

Crunching data... Almost there!

FMS key stats

USD
EUR
Millions
Billions
Annual
Quarterly
Trailing
Key stats
Income statement
Balance sheet
Cash Flow Statement
Valuation
Ratios
Per share
Per employee
Dividends & Yields
Crunching data... Almost there!

Discover more Stock Ideas

FAQ

1) What is Fresenius Medical Care AG & Co. KGaA's EPS?

As of today, Fresenius Medical Care AG & Co. KGaA's last 12-month EPS is $1.6, based on the financial report for Sep 30, 2024 (Q3 2024).

2) What is Fresenius Medical Care AG & Co. KGaA's EPS growth rate?

Over the last year, Fresenius Medical Care AG & Co. KGaA's EPS growth was (18.2%). The average annual EPS growth rates for Fresenius Medical Care AG & Co. KGaA have been (10.2%) over the past three years, (7.0%) over the past five years.

3) Is Fresenius Medical Care AG & Co. KGaA's EPS growth rate Good?

Over the last year, Fresenius Medical Care AG & Co. KGaA's EPS growth was (18.2%), which is lower than industry growth of 0.6%. It indicates that Fresenius Medical Care AG & Co. KGaA's EPS growth is Bad.

4) How does Fresenius Medical Care AG & Co. KGaA's EPS growth rate compare to its peers?

Over the last year, Fresenius Medical Care AG & Co. KGaA's EPS growth was (18.2%), which is lower than peer median growth of 41.3%. The list of peers includes THC, HCA, CHE, UHS, DVA, ENSG, EHC, AMED, ACHC, OPCH etc.